BOOTS IRELAND HAS announced that it is lowering the cost of the majority of its prescription medicines saying it will lead to significant savings for Irish customers.

The pharmacy says that across the top-ten most expensive prescription medicines, all medicines will reduce in price, giving customers an average saving of 25 per cent.

The new prices will come into effect from this Friday, 1 June.

Those living with chronic conditions and who are not eligible for the GMS Medical Card scheme stand to benefit the most if they purchase their medicines from one of the retailer’s 65 pharmacy outlets nationwide.

For example, a person living with asthma and who has a typical monthly medicine bill of €94.65 will see this bill drop to approximately €70.43 – a fall of 26 per cent that will save them €290.64 annually.

In another example, a typical person living with a cardiovascular condition such as high blood pressure and high cholesterol may see their medicine bill drop from €77.88 to €65.92 – a decrease of 15 per cent and representing an annual saving of up to €203.88.

Speaking about the announcement, Mary Rose Burke, Director of Pharmacy, Boots Ireland said: “In recent years, many of our customers have come under renewed financial pressures.

“In response to this, Boots Ireland is the first pharmacy retailer in Ireland to announce a commitment to delivering a clear and transparent pricing structure that will also result in significant savings for Boots Ireland customers.

Read: No clear timeline for approval of cannabis-based painkiller in Ireland

Read: One third of malaria drugs worldwide are fake – Lancet research

Read: Minister will approve skin cancer ‘wonder drug’ when reimbursement deal is agreed